TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

21.10$ -1.3% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Cullinan Oncology LLC (CGEM): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 3.2 % 23 Q4 23 · 44.9 % 23 Q1 24 · 13.1 % 24 Q2 24 · -2.7 % 24 Q3 24 · 10.4 % 24 Q4 24 · 1.7 % 24 Q1 25 · 8.6 % 25 Q2 25 · -28.9 % 25 Q3 25 · 13.5 % 25 Q4 25 · 11.9 % 25 Q1 26 · 10.7 % 26 Q2 26 · -14.1 % 26

EPS estimate beaten

Full history 14 of 30 quarters (47%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/14/2026 Cullinan Therapeutics, Inc. (CGEM): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/12/2026 Cullinan Therapeutics, Inc. (CGEM): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Cullinan Therapeutics, Inc. (CGEM): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?